Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant [0.03%]
移植物抗宿主病患者早期糖皮质激素依赖与初始糖皮质激素耐药的结局相似：移植后急性移植物抗宿主病患者的预后和治疗因素分析
Dilan A Patel,Karina A Mendoza,Heidi Chen et al.
Dilan A Patel et al.
Spontaneous Tumor Lysis Syndrome: A Rare Presentation in Plasmablastic Lymphoma [0.03%]
原发性肿瘤溶解综合征在浆细胞样淋巴瘤的罕见表现
Joana Infante,Andre Casado,Antonio Almeida et al.
Joana Infante et al.
Tumor lysis syndrome is an oncological emergency, which can ultimately lead to death if not recognized early and treated accordingly. The institution of adequate prophylactic measures can decrease its incidence and severity; but very rarely...
Case Reports
Journal of hematology. 2021 Feb;10(1):30-34. DOI:10.14740/jh620 2021
Histologic Transformation in an Untreated Waldenstrom's Macroglobulinemia After 14 Years: Case Report and Review of the Literature [0.03%]
十五年后无治疗华氏巨球蛋白血症组织学转化一例报告及文献复习
Elizabeth B Elimimian,Nadeem Bilani,Maria J Diacovo et al.
Elizabeth B Elimimian et al.
Waldenstrom's macroglobulinemia (WM) is an indolent B-cell non-Hodgkin lymphoma characterized by lymphoplasmacytic histology in the bone marrow with monoclonal IgM. Median survival can be in excess of 10 years. The 5-year cumulative inciden...
Case Reports
Journal of hematology. 2021 Feb;10(1):25-29. DOI:10.14740/jh767 2021
Tamoxifen Therapy for Recurrent Mucosal Bleeding in Hereditary Hemorrhagic Telangiectasia [0.03%]
他莫昔芬治疗遗传性出血性毛细血管扩张症反复发作的粘膜出血
Stephanie Yung,Julie-Anne Bell,Jim Brooker
Stephanie Yung
A 60-year-old Caucasian man had a 55-year history of recurrent severe epistaxis and later presented with multiple gastrointestinal (GI) bleeding from hereditary hemorrhagic telangiectasia (HHT). Bleeding was exacerbated due to coexistent mi...
Case Reports
Journal of hematology. 2021 Feb;10(1):22-24. DOI:10.14740/jh794 2021
Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease and the Role of the Classical Complement Pathway: A Case Report [0.03%]
一例镰状细胞病患者迟发型输血反应及经典补体途径的作用：个案报告
Pamela S Hair,Timothy P Heck,Daniel T Carr et al.
Pamela S Hair et al.
A 14-year-old female patient with sickle cell disease developed a severe delayed hemolytic transfusion reaction (DHTR) leading to multiple transfusions and intensive care management. To better understand the extent to which the classical co...
Case Reports
Journal of hematology. 2021 Feb;10(1):18-21. DOI:10.14740/jh553 2021
Bone Marrow Involvement by Aggressive B Cell Lymphoma Undetected by Aspirate Immunophenotyping [0.03%]
骨髓弥漫大B细胞淋巴瘤的浸润免疫分型抽吸标本假阴性分析
Habib Moshref Razavi
Habib Moshref Razavi
Staging for newly diagnosed lymphoma is an essential diagnostic step aimed at not only estimating prognosis but also refining the ensuing therapeutic pathway. Bone marrow is routinely sampled for this reason. Morphological assessment of the...
Case Reports
Journal of hematology. 2021 Feb;10(1):14-17. DOI:10.14740/jh766 2021
Use of a Mobile Intermittent Pneumatic Compression Device (Vekroosan) in Mobile Patients With Chronic Venous Disease [0.03%]
慢性静脉疾病患者的移动间歇气压装置(Vekroosan)使用研究
Raj Ramakrishna,William Alexander,Lina Baytieh
Raj Ramakrishna
Background: Compression therapy is an essential part of chronic venous disorder (CVD) treatment in reducing associated complications. This observational study aimed to note the use, effects and tolerance of a mobile inter...
A Pilot Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia [0.03%]
注射用硫酸长春地辛治疗复发或难治急性髓系白血病患者可行性和有效性的I期II期临床试验
Mary Beth Seegars,Ryan Woods,Leslie R Ellis et al.
Mary Beth Seegars et al.
Background: Resistance to therapy and a poor outcome characterize relapsed or refractory acute myeloid leukemia (AML). There is a clear need for additional palliative approaches with acceptable toxicities. Vincristine sul...
Molecular Genetic Analysis With Flow Cytometry Sorting Identifies Angioimmunoblastic T-Cell Lymphoma and Concomitant De Novo Myelodysplastic Syndrome Arising From the Same Hematopoietic Progenitor [0.03%]
采用流式细胞仪分选的分子遗传分析可识别出源自同一造血祖细胞的血管免疫母细胞性T细胞淋巴瘤及其伴发的新发骨髓增生异常综合征
Ken Naganuma,Alexander Chan,Yanming Zhang et al.
Ken Naganuma et al.
A 75-year-old man with no prior history of cytotoxic therapy presented with increasing fatigue and shortness of breath. He was found to have a new onset of pancytopenia, and chest X-ray showed severe pneumonia. Additional radiology exam rev...
Case Reports
Journal of hematology. 2020 Dec;9(4):140-146. DOI:10.14740/jh760 2020
Francesca Furia,Maria P Canevini,Augusto B Federici et al.
Francesca Furia et al.
Ruxolitinib is a highly potent JAK2 inhibitor approved for the treatment of myelofibrosis (idiopathic or post-polycythemia vera or post-essential thrombocythemia) and, more recently, for polycythemia vera with an inadequate response to or i...
Case Reports
Journal of hematology. 2020 Dec;9(4):137-139. DOI:10.14740/jh642 2020